Does ATORVASTATIN Cause Hepatic function abnormal? 520 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 520 reports of Hepatic function abnormal have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.7% of all adverse event reports for ATORVASTATIN.
520
Reports of Hepatic function abnormal with ATORVASTATIN
0.7%
of all ATORVASTATIN reports
17
Deaths
270
Hospitalizations
How Dangerous Is Hepatic function abnormal From ATORVASTATIN?
Of the 520 reports, 17 (3.3%) resulted in death, 270 (51.9%) required hospitalization, and 36 (6.9%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 520 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
CYCLOSPORINE (508)
CARBOPLATIN (498)
Which ATORVASTATIN Alternatives Have Lower Hepatic function abnormal Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM